Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Plasma Protein Therapeutics Market Growth 2022-2028

  • LP 4710443
  • 103 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Plasma Protein Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Plasma Protein Therapeutics market size is USD million in 2022 from USD 27460 million in 2021, with a change of % between 2021 and 2022. The global Plasma Protein Therapeutics market size will reach USD 44250 million in 2028, growing at a CAGR of 7.1% over the analysis period.

The United States Plasma Protein Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Plasma Protein Therapeutics market, reaching US$ million by the year 2028. As for the Europe Plasma Protein Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Plasma Protein Therapeutics players cover Shire (Baxalta), CSL, Grifols, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Protein Therapeutics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Coagulation Factor

Immune Globulin

Albumin

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hemophilia

PID

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Shire (Baxalta)

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Kamada

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Plasma Protein Therapeutics Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Plasma Protein Therapeutics by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Plasma Protein Therapeutics by Country/Region, 2017, 2022 & 2028

2.2 Plasma Protein Therapeutics Segment by Type

2.2.1 Coagulation Factor

2.2.2 Immune Globulin

2.2.3 Albumin

2.2.4 Others

2.3 Plasma Protein Therapeutics Sales by Type

2.3.1 Global Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

2.3.2 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2017-2022)

2.3.3 Global Plasma Protein Therapeutics Sale Price by Type (2017-2022)

2.4 Plasma Protein Therapeutics Segment by Application

2.4.1 Hemophilia

2.4.2 PID

2.4.3 Others

2.5 Plasma Protein Therapeutics Sales by Application

2.5.1 Global Plasma Protein Therapeutics Sale Market Share by Application (2017-2022)

2.5.2 Global Plasma Protein Therapeutics Revenue and Market Share by Application (2017-2022)

2.5.3 Global Plasma Protein Therapeutics Sale Price by Application (2017-2022)

3 Global Plasma Protein Therapeutics by Company

3.1 Global Plasma Protein Therapeutics Breakdown Data by Company

3.1.1 Global Plasma Protein Therapeutics Annual Sales by Company (2020-2022)

3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Company (2020-2022)

3.2 Global Plasma Protein Therapeutics Annual Revenue by Company (2020-2022)

3.2.1 Global Plasma Protein Therapeutics Revenue by Company (2020-2022)

3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Company (2020-2022)

3.3 Global Plasma Protein Therapeutics Sale Price by Company

3.4 Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Plasma Protein Therapeutics Product Location Distribution

3.4.2 Players Plasma Protein Therapeutics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Plasma Protein Therapeutics by Geographic Region

4.1 World Historic Plasma Protein Therapeutics Market Size by Geographic Region (2017-2022)

4.1.1 Global Plasma Protein Therapeutics Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Plasma Protein Therapeutics Annual Revenue by Geographic Region

4.2 World Historic Plasma Protein Therapeutics Market Size by Country/Region (2017-2022)

4.2.1 Global Plasma Protein Therapeutics Annual Sales by Country/Region (2017-2022)

4.2.2 Global Plasma Protein Therapeutics Annual Revenue by Country/Region

4.3 Americas Plasma Protein Therapeutics Sales Growth

4.4 APAC Plasma Protein Therapeutics Sales Growth

4.5 Europe Plasma Protein Therapeutics Sales Growth

4.6 Middle East & Africa Plasma Protein Therapeutics Sales Growth

5 Americas

5.1 Americas Plasma Protein Therapeutics Sales by Country

5.1.1 Americas Plasma Protein Therapeutics Sales by Country (2017-2022)

5.1.2 Americas Plasma Protein Therapeutics Revenue by Country (2017-2022)

5.2 Americas Plasma Protein Therapeutics Sales by Type

5.3 Americas Plasma Protein Therapeutics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Plasma Protein Therapeutics Sales by Region

6.1.1 APAC Plasma Protein Therapeutics Sales by Region (2017-2022)

6.1.2 APAC Plasma Protein Therapeutics Revenue by Region (2017-2022)

6.2 APAC Plasma Protein Therapeutics Sales by Type

6.3 APAC Plasma Protein Therapeutics Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Plasma Protein Therapeutics by Country

7.1.1 Europe Plasma Protein Therapeutics Sales by Country (2017-2022)

7.1.2 Europe Plasma Protein Therapeutics Revenue by Country (2017-2022)

7.2 Europe Plasma Protein Therapeutics Sales by Type

7.3 Europe Plasma Protein Therapeutics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Plasma Protein Therapeutics by Country

8.1.1 Middle East & Africa Plasma Protein Therapeutics Sales by Country (2017-2022)

8.1.2 Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2017-2022)

8.2 Middle East & Africa Plasma Protein Therapeutics Sales by Type

8.3 Middle East & Africa Plasma Protein Therapeutics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics

10.3 Manufacturing Process Analysis of Plasma Protein Therapeutics

10.4 Industry Chain Structure of Plasma Protein Therapeutics

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Plasma Protein Therapeutics Distributors

11.3 Plasma Protein Therapeutics Customer

12 World Forecast Review for Plasma Protein Therapeutics by Geographic Region

12.1 Global Plasma Protein Therapeutics Market Size Forecast by Region

12.1.1 Global Plasma Protein Therapeutics Forecast by Region (2023-2028)

12.1.2 Global Plasma Protein Therapeutics Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Plasma Protein Therapeutics Forecast by Type

12.7 Global Plasma Protein Therapeutics Forecast by Application

13 Key Players Analysis

13.1 Shire (Baxalta)

13.1.1 Shire (Baxalta) Company Information

13.1.2 Shire (Baxalta) Plasma Protein Therapeutics Product Offered

13.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Shire (Baxalta) Main Business Overview

13.1.5 Shire (Baxalta) Latest Developments

13.2 CSL

13.2.1 CSL Company Information

13.2.2 CSL Plasma Protein Therapeutics Product Offered

13.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CSL Main Business Overview

13.2.5 CSL Latest Developments

13.3 Grifols

13.3.1 Grifols Company Information

13.3.2 Grifols Plasma Protein Therapeutics Product Offered

13.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Grifols Main Business Overview

13.3.5 Grifols Latest Developments

13.4 Octapharma

13.4.1 Octapharma Company Information

13.4.2 Octapharma Plasma Protein Therapeutics Product Offered

13.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Octapharma Main Business Overview

13.4.5 Octapharma Latest Developments

13.5 Kedrion

13.5.1 Kedrion Company Information

13.5.2 Kedrion Plasma Protein Therapeutics Product Offered

13.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Kedrion Main Business Overview

13.5.5 Kedrion Latest Developments

13.6 LFB Group

13.6.1 LFB Group Company Information

13.6.2 LFB Group Plasma Protein Therapeutics Product Offered

13.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 LFB Group Main Business Overview

13.6.5 LFB Group Latest Developments

13.7 Biotest

13.7.1 Biotest Company Information

13.7.2 Biotest Plasma Protein Therapeutics Product Offered

13.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Biotest Main Business Overview

13.7.5 Biotest Latest Developments

13.8 BPL

13.8.1 BPL Company Information

13.8.2 BPL Plasma Protein Therapeutics Product Offered

13.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 BPL Main Business Overview

13.8.5 BPL Latest Developments

13.9 RAAS

13.9.1 RAAS Company Information

13.9.2 RAAS Plasma Protein Therapeutics Product Offered

13.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 RAAS Main Business Overview

13.9.5 RAAS Latest Developments

13.10 CBPO

13.10.1 CBPO Company Information

13.10.2 CBPO Plasma Protein Therapeutics Product Offered

13.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 CBPO Main Business Overview

13.10.5 CBPO Latest Developments

13.11 Hualan Bio

13.11.1 Hualan Bio Company Information

13.11.2 Hualan Bio Plasma Protein Therapeutics Product Offered

13.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Hualan Bio Main Business Overview

13.11.5 Hualan Bio Latest Developments

13.12 Kamada

13.12.1 Kamada Company Information

13.12.2 Kamada Plasma Protein Therapeutics Product Offered

13.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Kamada Main Business Overview

13.12.5 Kamada Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Plasma Protein Therapeutics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Plasma Protein Therapeutics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Coagulation Factor

Table 4. Major Players of Immune Globulin

Table 5. Major Players of Albumin

Table 6. Major Players of Others

Table 7. Global Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)

Table 8. Global Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

Table 9. Global Plasma Protein Therapeutics Revenue by Type (2017-2022) & ($ million)

Table 10. Global Plasma Protein Therapeutics Revenue Market Share by Type (2017-2022)

Table 11. Global Plasma Protein Therapeutics Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)

Table 13. Global Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Table 14. Global Plasma Protein Therapeutics Revenue by Application (2017-2022)

Table 15. Global Plasma Protein Therapeutics Revenue Market Share by Application (2017-2022)

Table 16. Global Plasma Protein Therapeutics Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Plasma Protein Therapeutics Sales by Company (2020-2022) & (K Units)

Table 18. Global Plasma Protein Therapeutics Sales Market Share by Company (2020-2022)

Table 19. Global Plasma Protein Therapeutics Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Plasma Protein Therapeutics Revenue Market Share by Company (2020-2022)

Table 21. Global Plasma Protein Therapeutics Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution and Sales Area

Table 23. Players Plasma Protein Therapeutics Products Offered

Table 24. Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Plasma Protein Therapeutics Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Plasma Protein Therapeutics Sales Market Share Geographic Region (2017-2022)

Table 29. Global Plasma Protein Therapeutics Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Plasma Protein Therapeutics Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Plasma Protein Therapeutics Sales Market Share by Country/Region (2017-2022)

Table 33. Global Plasma Protein Therapeutics Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Plasma Protein Therapeutics Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)

Table 36. Americas Plasma Protein Therapeutics Sales Market Share by Country (2017-2022)

Table 37. Americas Plasma Protein Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Plasma Protein Therapeutics Revenue Market Share by Country (2017-2022)

Table 39. Americas Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)

Table 40. Americas Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

Table 41. Americas Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)

Table 42. Americas Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Table 43. APAC Plasma Protein Therapeutics Sales by Region (2017-2022) & (K Units)

Table 44. APAC Plasma Protein Therapeutics Sales Market Share by Region (2017-2022)

Table 45. APAC Plasma Protein Therapeutics Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Plasma Protein Therapeutics Revenue Market Share by Region (2017-2022)

Table 47. APAC Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)

Table 48. APAC Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

Table 49. APAC Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)

Table 50. APAC Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Table 51. Europe Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)

Table 52. Europe Plasma Protein Therapeutics Sales Market Share by Country (2017-2022)

Table 53. Europe Plasma Protein Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2017-2022)

Table 55. Europe Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)

Table 56. Europe Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

Table 57. Europe Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)

Table 58. Europe Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Plasma Protein Therapeutics Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Plasma Protein Therapeutics Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Plasma Protein Therapeutics

Table 68. Key Market Challenges & Risks of Plasma Protein Therapeutics

Table 69. Key Industry Trends of Plasma Protein Therapeutics

Table 70. Plasma Protein Therapeutics Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Plasma Protein Therapeutics Distributors List

Table 73. Plasma Protein Therapeutics Customer List

Table 74. Global Plasma Protein Therapeutics Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Plasma Protein Therapeutics Sales Market Forecast by Region

Table 76. Global Plasma Protein Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Plasma Protein Therapeutics Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Plasma Protein Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Plasma Protein Therapeutics Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Plasma Protein Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Plasma Protein Therapeutics Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Plasma Protein Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Plasma Protein Therapeutics Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Plasma Protein Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Plasma Protein Therapeutics Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Plasma Protein Therapeutics Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Plasma Protein Therapeutics Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Plasma Protein Therapeutics Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Plasma Protein Therapeutics Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Plasma Protein Therapeutics Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Application (2023-2028)

Table 94. Shire (Baxalta) Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 95. Shire (Baxalta) Plasma Protein Therapeutics Product Offered

Table 96. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Shire (Baxalta) Main Business

Table 98. Shire (Baxalta) Latest Developments

Table 99. CSL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 100. CSL Plasma Protein Therapeutics Product Offered

Table 101. CSL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. CSL Main Business

Table 103. CSL Latest Developments

Table 104. Grifols Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 105. Grifols Plasma Protein Therapeutics Product Offered

Table 106. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Grifols Main Business

Table 108. Grifols Latest Developments

Table 109. Octapharma Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 110. Octapharma Plasma Protein Therapeutics Product Offered

Table 111. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Octapharma Main Business

Table 113. Octapharma Latest Developments

Table 114. Kedrion Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 115. Kedrion Plasma Protein Therapeutics Product Offered

Table 116. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Kedrion Main Business

Table 118. Kedrion Latest Developments

Table 119. LFB Group Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 120. LFB Group Plasma Protein Therapeutics Product Offered

Table 121. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. LFB Group Main Business

Table 123. LFB Group Latest Developments

Table 124. Biotest Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 125. Biotest Plasma Protein Therapeutics Product Offered

Table 126. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Biotest Main Business

Table 128. Biotest Latest Developments

Table 129. BPL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 130. BPL Plasma Protein Therapeutics Product Offered

Table 131. BPL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. BPL Main Business

Table 133. BPL Latest Developments

Table 134. RAAS Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 135. RAAS Plasma Protein Therapeutics Product Offered

Table 136. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. RAAS Main Business

Table 138. RAAS Latest Developments

Table 139. CBPO Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 140. CBPO Plasma Protein Therapeutics Product Offered

Table 141. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. CBPO Main Business

Table 143. CBPO Latest Developments

Table 144. Hualan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 145. Hualan Bio Plasma Protein Therapeutics Product Offered

Table 146. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. Hualan Bio Main Business

Table 148. Hualan Bio Latest Developments

Table 149. Kamada Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 150. Kamada Plasma Protein Therapeutics Product Offered

Table 151. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Kamada Main Business

Table 153. Kamada Latest Developments

List of Figures

Figure 1. Picture of Plasma Protein Therapeutics

Figure 2. Plasma Protein Therapeutics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Plasma Protein Therapeutics Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Plasma Protein Therapeutics Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Plasma Protein Therapeutics Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Coagulation Factor

Figure 10. Product Picture of Immune Globulin

Figure 11. Product Picture of Albumin

Figure 12. Product Picture of Others

Figure 13. Global Plasma Protein Therapeutics Sales Market Share by Type in 2021

Figure 14. Global Plasma Protein Therapeutics Revenue Market Share by Type (2017-2022)

Figure 15. Plasma Protein Therapeutics Consumed in Hemophilia

Figure 16. Global Plasma Protein Therapeutics Market: Hemophilia (2017-2022) & (K Units)

Figure 17. Plasma Protein Therapeutics Consumed in PID

Figure 18. Global Plasma Protein Therapeutics Market: PID (2017-2022) & (K Units)

Figure 19. Plasma Protein Therapeutics Consumed in Others

Figure 20. Global Plasma Protein Therapeutics Market: Others (2017-2022) & (K Units)

Figure 21. Global Plasma Protein Therapeutics Sales Market Share by Application (2017-2022)

Figure 22. Global Plasma Protein Therapeutics Revenue Market Share by Application in 2021

Figure 23. Plasma Protein Therapeutics Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Plasma Protein Therapeutics Revenue Market Share by Company in 2021

Figure 25. Global Plasma Protein Therapeutics Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region in 2021

Figure 27. Global Plasma Protein Therapeutics Sales Market Share by Region (2017-2022)

Figure 28. Global Plasma Protein Therapeutics Revenue Market Share by Country/Region in 2021

Figure 29. Americas Plasma Protein Therapeutics Sales 2017-2022 (K Units)

Figure 30. Americas Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)

Figure 31. APAC Plasma Protein Therapeutics Sales 2017-2022 (K Units)

Figure 32. APAC Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)

Figure 33. Europe Plasma Protein Therapeutics Sales 2017-2022 (K Units)

Figure 34. Europe Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Plasma Protein Therapeutics Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Plasma Protein Therapeutics Revenue 2017-2022 ($ Millions)

Figure 37. Americas Plasma Protein Therapeutics Sales Market Share by Country in 2021

Figure 38. Americas Plasma Protein Therapeutics Revenue Market Share by Country in 2021

Figure 39. United States Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Plasma Protein Therapeutics Sales Market Share by Region in 2021

Figure 44. APAC Plasma Protein Therapeutics Revenue Market Share by Regions in 2021

Figure 45. China Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Plasma Protein Therapeutics Sales Market Share by Country in 2021

Figure 52. Europe Plasma Protein Therapeutics Revenue Market Share by Country in 2021

Figure 53. Germany Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country in 2021

Figure 60. Egypt Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Plasma Protein Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics in 2021

Figure 66. Manufacturing Process Analysis of Plasma Protein Therapeutics

Figure 67. Industry Chain Structure of Plasma Protein Therapeutics

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390